Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
3 clinical trials · Condition
◉ Watch Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor (NCT04216563) | M.D. Anderson Cancer Center | 2020-07-29 |
| Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases (NCT00351975) | National Cancer Institute (NCI) | 2006-06-01 |
| Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia (NCT01445080) | National Cancer Institute (NCI) | 2006-05-30 |
Track Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.